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Abstract
Introduction: In almost half of all sepsis patients, acute kidney injury (AKI) develops. However, the pathobiologic
differences between sepsis patients with and without AKI are only poorly understood. We used a unique
opportunity to examine dynamic inflammatory, renal hemodynamic, and microvascular changes in two clinically
relevant large-animal models of sepsis. Our aim was to assess variability in renal responses to sepsis and to identify
both hemodynamic and nonhemodynamic mechanisms discriminating individuals with AKI from those in whom
AKI did not develop.
Methods: Thirty-six pigs were anesthetized, mechanically ventilated, and instrumented. After a recovery period,
progressive sepsis was induced either by peritonitis (n = 13) or by continuous intravenous infusion of live
Pseudomonas aeruginosa (n = 15). Eight sham operated-on animals served as time-matched controls. All animals
received standard intensive care unit (ICU) care, including goal-directed hemodynamic management. Before, and at
12, 18, and 22 hours of sepsis, systemic and renal (ultrasound flow probe) hemodynamics, renal cortex
microcirculation (laser Doppler), inflammation (interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-a), oxidative
stress (thiobarbituric acid reactive species (TBARS), nitrite/nitrate concentrations (NOx), and renal oxygen kinetics
and energy metabolism were measured.
Results: In 14 (50%) pigs, AKI developed (62% in peritonitis, 40% in bacteria infusion model). Fecal peritonitis
resulted in hyperdynamic circulation, whereas continuous bacteria infusion was associated with normodynamic
hemodynamics. Despite insults of equal magnitude, comparable systemic hemodynamic response, and uniform
supportive treatment, only those pigs with AKI exhibited a progressive increase in renal vascular resistance. This
intrarenal vasoconstriction occurred predominantly in the live-bacteria infusion model. In contrast to AKI-free
animals, the development of septic AKI was preceded by early and remarkable inflammatory response (TNF-a, IL-6)
and oxidative stress (TBARS).
Conclusions: The observed variability in susceptibility to septic AKI in our models replicates that of human disease.
Early abnormal host response accompanied by subsequent uncoupling between systemic and renal vascular
resistance appear to be major determinants in the early phase of porcine septic AKI. Nonuniform and model-
related renal hemodynamic responses that are unpredictable from systemic changes should be taken into
consideration when evaluating hemodynamic therapeutic interventions in septic AKI.
Introduction
The major importance of sepsis and acute kidney injury
(AKI) as a clinical and public health issue has clearly
been underscored by recent studies showing a steadily
increasing incidence of both syndromes [1,2]. Although
AKI is often a complex multifactorial syndrome, sepsis
and septic shock prevail as its dominant causes [3]. The
expanding population of patients with sepsis and AKI
and the associated excess mortality provide a strong
basis for further research aimed at establishing the
pathomechanisms and addressing more rigorously all
potentially modifiable factors to reduce this burden to
patients and the health care system. Considering that
AKI affects 40% to 50% of all sepsis patients [4-6], one
of the fundamental, yet unresolved, questions is why
AKI develops in some patients with sepsis, whereas the
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inflammatory pathogenic pathways contribute to devel-
opment of septic AKI (S-AKI), it is essential to under-
stand hemodynamic and nonhemodynamic differences
between subjects with S-AKI and those without AKI
[7,8]. Although preliminary data in humans suggest that
S-AKI is associated with systemic inflammation [9,10],
limited ability to analyze exactly the renal pathophysiol-
o g yi nh u m a n se m p h a s i z e st h en e e df o rc o m p l e x ,
dynamic, and clinically relevant animal studies [11].
Paradoxically, these animal models should replicate not
only the complexity of human sepsis, but also the varia-
bility among animals closely mimicking that seen in
clinical practice [11]. We took the unique opportunity
to analyze dynamic inflammatory, renal hemodynamic,
and microvascular changes in two clinically relevant
large-animal models that replicate many of the biologic
features of human septic shock, including the integra-
tion of standard day-to-day care resuscitative measures.
Our aim was to assess variability in renal responses to
sepsis and to identify both hemodynamic and nonhemo-
dynamic mechanisms that distinguish individuals with
AKI from AKI-free subjects. Because this modeling
allowed us to generate septic animals both with and
without S-AKI, the confounding effects of sepsis that
are independent of AKI could be isolated and studied
[12].
Materials and methods
All experiments were performed in adherence to the
National Institutes of Health Guidelines on the Use of
Laboratory Animals, and their protocols were approved
b yt h eU n i v e r s i t yA n i m a lC a r eC o m m i t t e e .T h i r t y - s i x
domestic pigs of either sex with a median body weight
of 35 (32 to 40) kg were used. Eight time-matched
sham-operated controls and 15 animals with sepsis
induced by continuous infusion of live bacteria (Pseudo-
monas aeruginosa) were studied prospectively. In addi-
tion, we performed a secondary analysis of 13 septic
animals that served as control groups in two rando-
mized prospective studies [13,14]. In these animals, sep-
sis was induced by fecal peritonitis. These two studies
addressed completely different questions, and the proto-
cols did not interfere with each other.
Anesthesia and surgical preparation
Anesthesia was induced with intravenous propofol (1 to
2 mg/kg) and ketamine (2 mg/kg). Animals were intu-
bated and mechanically ventilated with tidal volumes of
8 to 10 ml/kg, with positive end-expiratory pressure of
0.6 kPa, and FiO2 of 0.4. Respiratory rate was adjusted
to maintain normocapnia (arterial carbon dioxide ten-
sion, 4.0 to 5.0 kPa). During the surgical procedure, con-
tinuous infusions of fentanyl (10 to 15 μg/kg/h),
thiopental (10 mg/kg/h), and pancuronium (4 to 6 mg/
h) were administered. After surgical preparation, the
infusion of thiopental and fentanyl was decreased to 5
mg/kg/h and 5 μg/kg/h, respectively, and maintained
until the end of the experiment. Continuous infusion of
Plasmalyte (Baxter Healthcare, Deerfield, IL, USA) or
Ringerfundin solutions (Braun Melsungen Ag, Melsun-
gen, Germany) were used as a fluid replacement in
doses of 15 ml/kg/h during the surgery and reduced to
7 ml/kg/h thereafter. Normoglycemia (arterial blood glu-
cose level, 4.5 to 7 mmol/L) was maintained throughout
the whole experiment by using 20% glucose infusion as
needed.
Before the surgical procedure, a fiberoptic arterial
catheter was inserted into the femoral artery for contin-
uous blood pressure measurement, intermittent double-
indicator transpulmonary dilution (COLD Z-021; Pul-
sion Medical Systems GmbH, Munich, Germany), and
blood sampling. Central venous and pulmonary artery
catheters were introduced via jugular veins. Afterward, a
midline laparotomy was performed, and a precalibrated
ultrasound flowprobe (Transonic Systems, Ithaca, NY,
USA) was placed around the left renal artery. Laser
Doppler probe (PF 404, Suturable angled probe; Peri-
med, Jarfalla, Sweden) was placed directly over the renal
cortex for cortical microcirculation assessment, and a
double-lumen catheter was inserted into the left renal
vein for renal venous pressure measurements and blood
sampling. Peritoneal drainage was inserted before
abdominal wall closure, and epicystostomy was per-
formed under ultrasound control. A recovery period of
6 hours was provided before the baseline measurement.
Measurements and calculations
At each time point (baseline, 12, 18, and 22 hours after
induction of sepsis), the measurement of hemodynamics
included cardiac output (CO), systemic vascular resis-
tance (SVR), intrathoracic blood volume (ITBV), filling
pressures of both ventricles (CVP, PAOP), renal artery
blood flow (Qren), renal venous pressure (RVP), and
renal cortical microcirculation (LDF), as reported pre-
viously [13-15]. Renal vascular resistance was calculated
according to the formula:
RVR =

MAP

mm Hg

− RVP

mm Hg

/Qren

l.min−1
.
Arterial, mixed venous, and renal venous blood sam-
ples were analyzed for pH, pO2,p C O 2,a n df o rh e m o -
globin oxygen saturation. Systemic oxygen delivery,
systemic oxygen uptake, and renal oxygen delivery and
oxygen uptake were derived from the appropriate blood
gases and flow measurements.
Arterial and renal venous lactate and pyruvate concen-
trations were measured. Arterial blood samples were
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counts, tumor necrosis factor alpha (TNF-a), and inter-
leukin 6 (IL-6). Oxidative and nitrosative stress was
evaluated by measuring thiobarbituric acid reactive spe-
cies (TBARS) and nitrate/nitrite (NOx) concentrations.
To correct for dilution effects resulting from volume
resuscitation, NOx, TBARS, ADMA, IL-6, and TNF-a
levels were normalized for plasma protein content
[13-15]. AKI was defined according to the AKIN criteria
as an increase of more than 26.4 μmol/L or 150% in
serum creatinine from baseline [16].
Experimental protocols
The study consisted of three arms; intravenous live bac-
teria infusion (INFUSION, n = 15), fecal peritonitis
(PERITONITIS, n = 13), and sham-operated control
group (CONTROL, n = 8). In the infusion group, a con-
tinuous central venous infusion of Pseudomonas aerugi-
nosa (strain O1 isolated from a patient with suppurative
otitis, 1 × 10
9 colony-forming units/ml determined serial
dilution and colony counts) was commenced after base-
line data acquisition and maintained until the end of the
study. The infusion rate was titrated to a clinical goal of
moderate pulmonary hypertension (MPAP, 35 to 40
mm Hg). To avoid any variations in virulence, all pigs
were challenged with bacteria from the same bacterial
strain. In the peritonitis group, fecal peritonitis was
induced by inoculating 0.5 g/kg of autologous feces
incubated in 200 ml saline for 8 hours at 37°C through
the drains into the abdomen.
In addition to crystalloid solution, 6% hydroxyethyl
starch 130 kD/0.4 (Voluven 6%; Fresenius Kabi Deutsch-
land GmbH, Bad Homburg, Germany) was infused to
maintain normovolemia in a goal-directed fashion,
guided by filling pressures response and ITBV measure-
ment. Continuous IV noradrenaline was administered if
mean arterial pressure (MAP) fell below 65 mm Hg and
titrated to maintain MAP above 70 mm Hg. When the
last set of data had been obtained, the animals were
killed by potassium chloride injection under deep
anesthesia, and section was performed.
Statistical analysis
All values shown are median and interquartile range.
The calculations were done by using SigmaStat software
version 3.5 (Systat Software Inc., Erkrath, Germany).
After exclusion of normality by using the Kolmogorov-
Smirnov test, time-dependent changes within each
g r o u pw e r et e s t e db yu s i n gt h eF r i e d m a nA N O V Ao n
ranks and, subsequently, the Dunn test for multiple
comparisons with the Bonferroni correction. Differences
between the groups were analyzed by using the Kruskal-
Wallis one-way analysis of variance on ranks or the
Mann-Whitney rank sum test when only two sets of
measurements were compared. A value of P <0 . 0 5w a s
regarded as statistically significant.
Results
Characterization of sepsis models
All animals completed the whole protocol. Hemody-
namic and oxygen-exchange parameters, inflammatory
responses, oxidative stress, and other laboratory para-
meters are summarized in Table 1. Fecal peritonitis
induced a hyperdynamic circulatory state with an
increased cardiac output, whereas continuous bacteria
infusion resulted in normodynamic circulation. Sepsis
significantly decreased systemic vascular resistance in
both groups, the effect being more pronounced in the
Peritonitis group. Although pigs in the Infusion group
received higher cumulative amount of fluids (469 (407
to 516) versus 387 (344 to 425) ml/kg in the Infusion
and Peritonitis groups, respectively; P = 0.007), fluid
resuscitation maintained ITBV without intergroup dif-
ferences, suggesting comparable cardiac preload. Twelve
(85%) animals in the Infusion group received noradrena-
line infusion, whereas seven (54%) pigs required vaso-
pressor support in the Peritonitis group to maintain
MAP ≥ 70 mm Hg. The average dose of noradrenalin
was higher in the Peritonitis group (1.47 (0.69 to 2.67)
versus 0.25 (0.1 to 0.54) μg/kg/min; P = 0.012), but the
time to start the vasopressor infusion was similar in
both groups (1,277 (1,205 to 1,335) versus 1,035 (869 to
1,401) minutes in the Infusion and Peritonitis groups,
respectively). In the Peritonitis group, the increased car-
diac output resulted in a significant increase of systemic
oxygen delivery, whereas systemic oxygen consumption
did not change in any of the three groups over time.
Sepsis induced acute lung injury in both sepsis groups,
as documented by significant, progressive deterioration
of the PaO2/FiO2 ratio. Both models of sepsis markedly
increased plasma levels of TNF-a and IL-6, without sta-
tistically significant intergroup differences. These
changes were accompanied by a remarkable increase of
thiobarbituric acid reactive species (TBARS) levels, in
particular in the peritonitis model, providing the evi-
dence for oxidative stress.
Characteristics of animals with and without S-AKI
Overall, S-AKI developed in 14 (50%) of 28 animals;
62% met criteria for AKI in the Peritonitis group, and
40%, in the Infusion group. Within the period of the
experiment, 86% of these pigs reached AKIN stage I,
and 14%, AKIN stage II. No statistically significant dif-
ferences in any measured variables were found between
AKI-free and AKI pigs at baseline. The gender distribu-
tion was homogeneous in both groups. Similarly, the
total amount of infused P. aeruginosa was identical (24
(18 to 43) ml in the AKI-free versus 24 (16 to 35) ml in
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quantification of bacterial load could not be assessed.
Nevertheless, no statistically significant intergroup dif-
ferences in systemic hemodynamic variables were seen
during the course of the experiment (Table 2). In addi-
tion, neither total amount of fluids nor vasopressor
requirement differed between AKI and AKI-free ani-
mals, suggesting comparable infectious insults. Nine of
14 (64%) pigs in the AKI group and 10 (71%) of 14
AKI-free animals were given noradrenaline infusion.
Total dose of noradrenalin was 0.21 (0.01 to 0.42) versus
0.12 (0.05 to 0.22) mg/kg; P =0 . 5 6i nt h eA K Ia n dt h e
Table 1 Characterization of sepsis models
Baseline 12 hours 18 hours 22 hours
Mean arterial pressure (mm Hg)
Control 95 [87-109] 86.5 [83-94] 80 [73-90] 84 [68-87]
Infusion 112 [103-122] 88 [79-100]
a 82 [77-90]
a 79 [74-88]
a
Peritonitis 97 [92-104] 89 [73-99] 81 [69-97]
a 76 [68-91]
a
Cardiac output (ml/kg)
Control 98 (90-105) 97 (85-100) 80 (76-87) 85 (77-98)
Infusion 90 (80-101) 98 (80-128) 98 (81-130) 106 (83-145)
Peritonitis 81 (67-97) 118 (97-148)
a 129 (110-157)
ab 152 (101-181)
ab
Systemic vascular resistance (dyne.s.cm
-5)
Control 2,453 (1,838-2,700) 2,075 (1,935-2,299) 1,961 (1,872-2,169) 1,912 (1,648-2,262)
Infusion 2,457 (1,956-2,643) 1,562 (1,384-1,788)
a 1,382 (1,116-1,698)
ab 1,179 (873-1,692)
a
Peritonitis 2,737 (2,003-2,858) 1,635 (1,102-1,978)
b 1,165 (849-1,595)
ab 853 (651-1,393)
ab
ITBVI (ml/kg)
Control 31 (28-33) 24 (21-34) 23 (21-30) 26 (23-28)
Infusion 27 (22-29) 25 (22-27) 24 (20-28) 23 (21-24)
Peritonitis 23 (22-26) 26 (22-31) 27 (23-29) 23 (19-34)
DO2 systemic (ml/min/kg)
Control 11.9 (9.9-12.2) 11.1 (9.3-12.1) 9.2 (8.7-10.7) 9.6 (8.8-10.3)
Infusion 11.5 (9.6-12.5) 12 (9.2-15.5)
c 12.2 (10.1-15) 11.9 (9.6-16.1)
c
Peritonitis 11.4 (9-13.6) 16 (14.5-23.2)
b 16.4 (15-21.9)
ab 22.1 (13.4-24.5)
ab
VO2 systemic (ml/min/kg)
Control 5.6 (4.6-5.9) 5.5 (5.2-5.7) 4.8 (4.7-5.8) 3.3 (2.7-4.3)
a
Infusion 4.5 (4.2-5.0) 5.2 (5-7.4)
a 5.1 (4.7-6.9) 4.6 (3.5-6.2)
Peritonitis 4.8 (4.3-5.6) 5.9 (5.2-6.8) 5.6 (4.8-6.3) 7.2 (4.2-9.5)
PaO2/FiO2 (mm Hg)
Control 489 (445-514) 399 (374-456) 412 (320-434) 432 (272-449)
Infusion 463 (348-502) 251 (164-352)
ab 292 (191-350) 135 (66-205)
ab
Peritonitis 456 (336-497) 340 (309-381) 173 (115-305)
b 137 (80-286)
a
TNF-a (pg/g of protein)
Control 1 (1-5) 3 (1-5) 2 (1-6) 2 (1-5)
Infusion 2 (2-3) 5 (4-7)
a 16 (10-23)
ab 13 (7-25)
ab
Peritonitis 1 (1-2) 7 (5-10)
ab 13 (5-24)
ab 18 (5-33)
ab
IL-6 (pg/g of protein)
Control 2 (1-2) 1 (1-1)
a 1 (0-1)
a 1 (1-2)
Infusion 2 (1-5) 7 (5-18)
b 34 (27-101)
ab 72 (23-175)
ab
Peritonitis 3 (1-5) 29 (11-193)
ab 126 (16-484)
ab 203 (20-1,296)
ab
TBARS (nmol/g of protein)
Control 16 (14-18) 19 (16-28)
a 24 (18-34)
a 23 (16-26)
a
Infusion 14 (13-15)
c 22 (19-27)
c 32 (23-39)
ac 30 (27-46)
ac
Peritonitis 18 (17-24) 52 (37-76)
ab 84 (51-114)
ab 70 (46-107)
ab
Control, sham-operated group; DO2 systemic, systemic oxygen delivery; IL-6, interleukin 6; Infusion, sepsis induced by bacterial infusion; ITBV, intrathoracic blood
volume; PaO2/FiO2, ratio between arterial oxygen tension and the inspired fraction; Peritonitis, peritonitis-induced group; TBARS, thiobarbituric acid-reactive
species; TNF-a, tumour necrosis factor alpha; VO2 systemic, systemic oxygen uptake;
asignificant difference within each group versus baseline (P < 0.05);
bsignificant difference between the Control group and any of the septic groups (P < 0.05);
csignificant difference of the Infusion versus the Peritonitis group
(P < 0.05).
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noradrenalin infusion was identical (935 (816 to 1,368)
minutes for AKI versus 1,133 (900 to 1,420) minutes for
AKI-free; P = 0.87).
Both groups had no changes in systemic oxygen con-
sumption (Table 2). Significantly greater metabolic
acidosis and higher arterial lactate/pyruvate ratio were
noted in the animals that developed AKI over the ones
that did not (Table 2). Despite comparable systemic
hemodynamics and vasopressor support, only those ani-
mals with AKI had very early and remarkable increase
in serum TNF-a and TBARS levels (Figure 1). Signifi-
cant increase in these markers occurred later in the
non-AKI group (Figure 1). Although a clear-cut ten-
dency of plasma IL-6 levels was seen to increase more
markedly in the AKI group, the intergroup differences
did not reach statistical significance (Figure 1, lower
panel).
Renal effects of sepsis in pigs with and without AKI
Serum creatinine levels increased significantly in AKI
animals by the end of the experiment, whereas no
Table 2 Characteristics of animals with and without S-AKI
Baseline 12 hours 18 hours 22 hours
Mean arterial pressure (mm Hg)
AKI 106 (97-115) 82 (72-99)
a 82 (70-96)
a 76 (62-88)
a
Non-AKI 104 (90-114) 92 (80-100) 82 (76-91)
a 78 (73-87)
a
Control 95 (87-109) 87 (83-94) 80 (73-90) 84 (68-87)
Cardiac output (ml/kg)
AKI 93 (68-103) 103 (94-139) 125 (97-157)
b 107 (93-153)
Non-AKI 85 (79-97) 106 (76-137) 109 (82-129)
a 145 (98-168)
ab
Control 98 (90-105) 97 (85-100) 80 (76-87) 85 (77-98)
Systemic vascular resistance (dyne.s.cm
-5)
AKI 2,693 (1,912-2,826) 1,437 (846-1,840)
ab 1,097 (722-1,333)
ab 1,121 (809-1,663)
ab
Non-AKI 2,477 (2,355-2,712) 1,676 (1,539-1,973)
a 1,489 (1,282-1,699)
ab 1,113 (819-1,668)
ab
Control 2,453 (1,838-2,700) 2,075 (1,935-2,299) 1,961 (1,872-2,169) 1,912 (1,648-2,262)
ITBVI (ml/kg)
AKI 23 (21-29) 25 (19-30) 27 (22-31) 21 (18-24)
Non-AKI 26 (23-29) 26 (23-30) 24 (21-26) 24 (22-29)
Control 31 (28-33) 24 (21-34) 23 (21-30) 26 (23-28)
Fluid intake (ml/kg/h)
AKI 12 (9-14) 16 (15-17)
a 18 (14-18)
a 13 (9-16)
Non-AKI 13 (12-15) 18 (17-22)
a 18 (17-22) 17 (13-22)
Control 13 (11-17) 16 (13-21) 13 (13-18) 13 (10-15)
VO2 systemic (ml/min/kg)
AKI 4.8 (4.6-5.2) 6.0 (5.0-7.4) 5.6 (4.8-7.0) 5.8 (4.2-8.6)
Non-AKI 4.4 (4.1-5.1) 5.4 (4.9-6.2) 5.3 (4.6-6.1) 4.2 (3.5-7.3)
Control 5.6 (4.6-5.9) 5.5 (5.2-5.7) 4.8 (4.7-5.8) 3.3 (2.7-4.3)
a
Arterial base excess (mmol/L)
AKI 6 (5-8.5) 4 (-0.6-7.5) 2.7 (-8.6-6.5) 1.4 (-8.7-3.8)
ab
Non-AKI 6.6 (4.7-11.8) 5.6 (4.7-8.5) 4.1 (2.7-6.7) 2.2 (1.1-7.7)
a
Control 8.5 (6.9-12.6) 7.7 (6.7-8.3) 7.6 (5.1-11.2) 6.1 (5.1-7.3)
Arterial lactate-to-pyruvate ratio
AKI 10 (5-18) 15 (10-23) 36 (19-72)
a 38 (21-60)
a
Non-AKI 10 (8-22) 12 (10-15) 22 (10-39) 20 (10-85)
Control 9 (8-26) 17 (12-29) 17 (11-75) 15 (10-37)
NOx (μmol/g of protein)
AKI 0.8 (0.6-1) 1 (0.7-1.7) 1.4 (1-2) 1.3 (1-1.7)
a
Non-AKI 0.8 (0.7-1) 0.8 (0.5-1.2) 0.9 (0.7-1.3) 1 (0.8-1.7)
a
Control 1.1 (0.8-1.4) 0.6 (0.5-0.7)
a 0.7 (0.6-0.9) 0.8 (0.6-1)
Control, sham-operated group; IL-6, interleukin 6; Infusion, sepsis induced by bacterial infusion; ITBV, intrathoracic blood volume; NOx, nitrite/nitrate
concentration; PaO2/FiO2, ratio between arterial oxygen tension and the inspired fraction; Peritonitis, peritonitis-induced group, TBARS, thiobarbituric acid-reactive
species; VO2 systemic, systemic oxygen uptake;
asignificant difference within each group versus baseline (P < 0.05);
bsignificant difference between the Control
group and any of the septic groups (P < 0.05).
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Page 5 of 14Figure 1 Biomarkers of inflammatory response during the course of sepsis. Plasma levels of inflammatory and oxidative stress markers
(tumor necrosis factor a, upper panel; thiobarbituric acid-reactive species, middle panel; and IL-6, interleukin 6, lower panel) in control, non-AKI,
and AKI animals. AKI, septic animals with acute kidney injury; control, sham operated; non-AKI, septic animals without acute kidney injury
development. *Significant difference within each group versus baseline (P < 0.05);
#significant difference between the control group and any of
the septic groups (P < 0.05);
$significant difference of the AKI versus the non-AKI group (P < 0.05).
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(Table 3). Urine output decreased markedly in AKI ani-
mals, whereas it transiently and significantly increased
in AKI-free animals (Table 2). As opposed to subjects
that remained AKI free, those in which AKI developed
exhibited an increase in renal vascular resistance at the
end of the experiment (Figure 2, upper panel). As com-
pared with the Control group, the renal-to-systemic vas-
cular resistances index more than doubled in the AKI
groups (Figure 2, middle panel). This renal vasoconstric-
tion, also apparent from the relative changes from base-
line (RVR change, Table 3), was accompanied by a
reduction in renal blood flow. No changes in renal
blood flow occurred in AKI-free animals (Figure 2,
lower panel). Despite maintained mean arterial pressure
with noradrenaline above 70 mm Hg, renal perfusion
pressure decreased significantly in both groups, partly as
a result of gradually increased renal venous pressure
(Table 3). Nevertheless, no significant intergroup differ-
ences occurred. Reduced renal blood flow observed in
AKI animals was accompanied by decreased renal oxy-
gen delivery and oxygen con s u m p t i o na tt h ee n do ft h e
experiment, whereas no changes were detected in AKI-
free pigs over time (Table 3). As compared with baseline
values, the renal cortical microcirculatory blood flow
decreased both in AKI-free and in the AKI group, with
earlier deterioration observed in pigs with AKI (Table
3). Kidneys in AKI animals showed more marked meta-
bolic stress, as evidenced by a significant development
of renal venous metabolic acidosis and a tendency
toward increased renal venous lactate/pyruvate ratio
(Table 3).
Renal effects of sepsis in pigs with AKI: comparison of
sepsis models
Data comparing renal responses to different septic mod-
els are shown in Table 4 in the following order: bacteria
infusion with AKI (AKI-INF; n =6 )a n dw i t h o u tA K I
(NONAKI-INF; n = 9), and peritonitis with AKI (AKI-
PERIT; n =8 )a n dw i t h o u tA K I( N O N A K I - P E R I T ;n =
5). Individual responses are depicted in Figures 3 and 4.
Increase in serum creatinine levels reached similar
values in both groups at the end of the experiment
(Table 4). No significant differences were noted in the
amount of hydroxyethylstarch between any of the sub-
groups analyzed. Although renal vascular resistance
increased gradually in the AKI group induced by live
bacteria infusion, it remained unchanged in AKI animals
challenged with peritonitis (Table 4 Figure 3). However,
wide interindividual responses were observed even in
the Peritonitis group (Figure 3). In addition, when com-
pared with baseline values, the renal-to-systemic vascu-
lar resistances ratio increased in both groups of animals
developing AKI, whereas it remained unchanged in
AKI-free pigs in the Peritonitis group (Table 4). Indivi-
dual relations between renal and systemic vascular resis-
tances in the particular groups are shown in Figure 4.
Renal blood flow and cortical microvascular perfusion
decreased in both AKI models, without any intergroup
Table 3 Renal effects of sepsis in pigs with and without
acute kidney injury
Baseline 12 hours 18 hours 22 hours
Creatinine (μmol/L)
AKI 98 (88-105) 105 (91-134) 124 (89-164) 137 (130-176)
abc
Non-AKI 94 (90-109) 96 (81-102) 95 (87-106) 101 (89-111)
Control 83 (75-96) 82 (72-100) 90 (76-101) 88 (77-99)
Diuresis (ml/kg/h)
AKI 1.5 (1.3-2) 2.0 (1.6-2.8) 2.1 (0.9-4.7) 0.7 (0.1-1.2)
bc
Non-AKI 1.9 (1.4-2.4) 4.2 (2.7-4.9)
a 4.2 (2.2-6.4)
a 1.5 (1.2-3.2)
Control 2.4 (1.8-3.2) 3.9 (2.3-6.6) 3.3 (2.5-5.7) 2.2 (1.8-3.2)
Renal perfusion pressure (mm Hg)
AKI 91 (85-101) 70 (58-83) 64 (55-78)
a 60 (53-73)
a
Non-AKI 91 (76-97) 76 (64-83) 65 (57-71)
a 59 (52-69)
a
Control 86 (78-91) 70 (68-82) 67 (59-77)
a 71 (51-77)
a
Renal venous pressure (mm Hg)
AKI 14 (12-15) 17 (15-19) 18 (18-19)
ab 19 (18-21)
a
Non-AKI 14 (11-15) 16 (15-17) 18 (15-20)
a 20 (18-22)
a
Control 11 (9-16) 14 (13-16) 14 (12-16) 17 (13-18)
Change of renal vascular resistance from baseline (%)
AKI 100 (100-100) 114 (78-145) 111 (95-183) 242 (121-9,430)
abc
Non-AKI 100 (100-100) 94 (75-110) 82 (58-113) 92 (69-112)
Control 100 (100-100) 112 (89-118) 101 (63-125) 81 (59-118)
Renal VO2 (ml/min/kg)
AKI 0.2 (0.2-0.3) 0.2 (0.1-0.3) 0.2 (0.1-0.2) 0.1 (0-0.2)
a
Non-AKI 0.2 (0.1-0.2) 0.2 (0.2-0.2) 0.2 (0.2-0.2) 0.2 (0.2-0.2)
Control 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.1 (0.1-0.2) 0.2 (0.1-0.2)
Renal cortical microcirculation (laser Doppler flowmetry) (% of
baseline value)
AKI 100 (100-100) 61 (43-80)
ab 62 (45-97)
a 48 (27-67)
a
Non-AKI 100 (100-100) 70 (57-108) 70 (60-100) 61 (49-86)
a
Control 100 (100-100) 97 (73-125) 70 (63-109) 73 (58-118)
Base excess renal vein (mmol/L)
AKI 7.3 (6.1-8.5) 3.3 (0.1-6.7)
b 2.9 (-5.6-6.7) -1.9 (-11.8-3.3)
ab
Non-AKI 8.9 (6.7-11) 6.2 (5.4-9.1) 4.9 (3.9-9.1) 4.1 (1.6-10.2)
Control 8.7 (7-13.7) 7.8 (6.9-9.7) 7.8 (5.3-9.6) 6.7 (4.8-7.4)
Lactate/pyruvate ratio: renal vein
AKI 11 (7-17) 15 (12-21) 20 (9-43) 28 (18-43)
Non-AKI 10 (7-20) 7 (5-18) 13 (5-27) 10 (7-19)
Control 16 (9-21) 7 (6-20) 16 (7-32) 8 (6-17)
AKI, septic animals with acute kidney injury; Control, sham-operated group;
DO2 systemic, systemic oxygen delivery; IL-6, interleukin 6; Infusion, sepsis
induced by bacterial infusion; ITBV, intrathoracic blood volume; Non-AKI,
septic animals without acute kidney injury development; PaO2/FiO2, ratio
between arterial oxygen tension and the inspired fraction; Peritonitis,
peritonitis-induced group; renal VO2, renal oxygen uptake; TBARS,
thiobarbituric acid-reactive species; TNF-a, tumor necrosis factor alpha; VO2
systemic, systemic oxygen uptake;
asignificant difference within each group
versus baseline (P < 0.05);
bsignificant difference between the Control group
and any of the septic groups (P < 0.05);
csignificant difference of the AKI
versus the Non-AKI group (P < 0.05).
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Page 7 of 14Figure 2 Changes in renal hemodynamics during the course of sepsis. Changes in renal vascular resistance (upper panel), renal-to-systemic
vascular resistance ratio (middle panel), and renal blood flow (lower panel) in control, non-AKI, and AKI animals. AKI, septic animals with acute
kidney injury; control, sham operated; non-AKI, septic animals without acute kidney injury developement; *significant difference within each
group versus baseline (P < 0.05);
#significant difference between the control group and any of the septic groups (P < 0.05); $significant
difference of the AKI versus the non-AKI group (P < 0.05).
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Page 8 of 14Table 4 Renal effects of sepsis in pigs with and without acute kidney injury: comparison of sepsis models
Baseline 12 hours 18 hours 22 hours
Creatinine (μmol/L)
AKI-INF 95 (84-114) 92 (88-148) 105 (85-168) 150 (134-180)
ab
AKI-PERIT 98 (93-105) 107 (97-128) 129 (112-158)
c 131 (129-166)
ac
NONAKI-INF 106 (97-120) 100 (95-107) 102 (95-110) 109 (95-117)
NONAKI-PERIT 91 (84-91) 81 (78-96) 81 (77-91) 89 (84-94)
Renal vascular resistance (mm Hg/L/min)
AKI-INF 359 (235-635) 373 (288-700) 576 (273-1,161) 2,433 (1061-2,727)
a
AKI-PERIT 376 (302-459) 448 (280-637) 516 (236-821) 464 (404-1,425)
NONAKI-INF 471 (352-539) 388 (341-503) 415 (315-556) 355 (325-779)
NONAKI-PERIT 500 (431-541) 386 (320-407) 302 (273-340)
a 383 (339-438)
Renal-to-systemic vascular resistance ratio
AKI-INF 14 (11-17) 21 (13-32) 28 (17-58) 94 (49-170)
a
AKI-PERIT 12 (10-14) 25 (14-59) 39 (20-59)
a 38 (20-143)
a
NONAKI-INF 15 (14-19) 18 (16-35) 23 (16-40) 30 (19-63)
a
NONAKI-PERIT 16 (14-16) 18 (13-21) 16 (15-17) 24 (18-48)
Renal flow (ml/min/kg)
AKI-INF 6 (6-11) 6 (3-8) 4 (2-7) 1 (1-2)
a
AKI-PERIT 7 (5-8) 4 (3-5) 4 (2-6) 3 (1-4)
a
NONAKI-INF 5 (4-7) 4 (3-5) 5 (3-5) 4 (2-5)
NONAKI-PERIT 6 (5-6) 7 (6-8) 7 (7-9)
a 6 (4-6)
Renal cortical microcirculation (laser Doppler flowmetry) (% of baseline value)
AKI-INF 100 (100-100) 70 (57-105) 67 (55-97) 35 (25-51)
a
AKI-PERIT 100 (100-100) 59 (36-72)
a 61 (41-85) 57 (32-75)
a
NONAKI-INF 100 (100-100) 63 (53-111) 64 (52-101) 65 (47-92)
NONAKI-PERIT 100 (100-100) 88 (70-99) 75 (62-111) 59 (49-85)
a
Diuresis (ml/kg/h)
AKI-INF 1.7 (1-2.7) 2.7 (2.2-8) 4.8 (1.8-8.1) 1.1 (0.1-3.8)
AKI-PERIT 1.5 (1.3-1.9) 1.8 (1.5-2.3) 1.6 (0.9-2.1) 0.6 (0.2-0.9)
ac
NONAKI-INF 2.2 (1.3-2.5) 4.5 (3.8-5.5)
a 4.2 (1.7-5.4) 1.3 (1-2.3)
NONAKI-PERIT 1.6 (1.3-2.4) 2.3 (2-4.8) 3.9 (2.9-6.5) 1.7 (1.5-3.6)
TNF-a (pg/g of protein)
AKI-INF 2 (2-3) 8 (6-19)
a 14 (12-31)
a 25 (20-42)
a
AKI-PERIT 1 (1-3) 10 (5-16) 18 (5-30)
a 18 (5-105)
a
NONAKI-INF 2 (1-3) 4 (4-5) 18 (10-22)
a 7 (6-15)
a
NONAKI-PERIT 1 (1-1) 3 (2-7) 9 (5-15) 16 (6-30)
a
IL-6 (pg/g of protein)
AKI-INF 2 (1-5) 62 (5-104) 70 (33-130)
a 155 (67-383)
a
AKI-PERIT 3 (1-8) 118 (28-327) 246 (70-1,161)
a 284 (68-3,981)
a
NONAKI-INF 2 (2-5) 6 (5-10) 32 (27-51)
a 61 (18-84)
a
NONAKI-PERIT 3 (1-4) 12 (6-29) 19 (5-221) 33 (7-1,186)
a
NOx (μmol/g of protein)
AKI-INF 0.8 (0.6-1) 0.7 (0.6-0.7) 0.9 (0.7-1.4) 1.3 (0.9-1.5)
AKI-PERIT 0.8 (0.6-1.1) 1.6 (1.2-3)
ad 1.6 (1.3-3.5)
a 1.1 (1-2.1)
NONAKI-INF 0.9 (0.6-1.1) 0.5 (0.4-0.8) 0.7 (0.5-1) 0.8 (0.7-1.4)
NONAKI-PERIT 0.8 (0.7-0.9) 1.2 (1-1.5) 1.3 (0.8-1.7) 1.5 (1.3-1.7)
a
TBARS (pg/g of protein)
AKI-INF 14 (11-15) 26 (14-41) 31 (24-36)
a 36 (27-61)
a
AKI-PERIT 21 (18-25)
d 68 (49-93)
ad 90 (58-129)
ad 75 (55-132)
a
NONAKI-INF 14 (13-14) 22 (19-23) 32 (22-39)
a 30 (27-40)
a
NONAKI-PERIT 18 (16-21) 35 (32-48) 77 (44-91)
a 62 (39-106)
a
AKI, septic animals with acute kidney injury; Control, sham-operated group; DO2 systemic, systemic oxygen delivery; IL-6, IL-6, interleukin 6; interleukin 6; INF,
sepsis induced by bacterial infusion; ITBV, intrathoracic blood volume; NONAKI, septic animals without acute kidney injury development; Nox, nitrite/nitrate
concentrations;PaO2/FiO2, ratio between arterial oxygen tension and the inspired fraction; PERIT, peritonitis-induced group; TBARS, thiobarbituric acid-reactive
species; TNF-a, tumor necrosis factor alpha; VO2 systemic, systemic oxygen uptake;
asignificant difference within each group versus baseline (P < 0.05);
bsignificant difference of the AKI-INF versus the NONAKI-INF group (P < 0.05);
csignificant difference of the AKI-PERIT versus the NONAKI-PERIT group (P < 0.05);
dsignificant difference of the AKI-PERIT versus the AKI-INF group (P < 0.05).
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Page 9 of 14differences. Despite apparent intrarenal vasoconstriction,
only two (33%) animals in the AKI group induced by
live bacteria infusion developed oliguria. By contrast,
seven (88%) pigs became oliguric in the Peritonitis-
induced AKI. No statistically significant differences in
systemic inflammatory responses were found between
pigs in both sepsis models with AKI, although those ani-
mals that developed AKI in the Peritonitis group had
earlier and apparently greater increases of IL-6 levels. In
addition, animals with AKI in the Peritonitis group had
Figure 3 Individual changes in renal vascular resistance in the AKI, non-AKI, and control groups. Dashed line, infusion groups; solid line,
Peritonitis and Control; bold line, median; TP 1 to 4, time points 1 to 4; AKI, septic animals with acute kidney injury; Control, sham-operated group;
Infusion, sepsis induced by bacterial infusion; non-AKI, septic animals without acute kidney injury developement; Peritonitis, peritonitis-induced
group; *significant difference within each group versus baseline (P < 0.05);
$significant difference of the AKI versus the non-AKI group (P < 0.05).
Figure 4 Individual changes in renal and systemic vascular resistances in the AKI and non-AKI groups. Lines indicate the individual
connection between the baseline values of renal (x-axis) and systemic (y-axis) vascular resistances and the values measured after 22 hours of
sespis. Arrow, the direction of change. Only AKI and non-AKI groups are displayed. Dashed line, infusion groups; solid line, peritonitis; bold line,
median; AKI, septic animals with acute kidney injury; infusion, sepsis induced by bacterial infusion; non-AKI, septic animals without acute kidney
injury developement; peritonitis, peritonitis-induced group.
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Page 10 of 14larger production of nitric oxide and reactive nitrogen
species, as documented by significantly increased NOx
and TBARS levels at 12 and 18 hours of sepsis (Table
4).
Discussion
We have developed two clinically relevant large-animal
models allowing us to study the renal responses to sep-
sis. A unique feature of these models is variability in
susceptibility to the development of S-AKI that closely
replicates that of human disease. This heterogeneity
allowed us to isolate and study factors discriminating
AKI from non-AKI. Abnormal host response to sepsis,
characterized by early systemic inflammation and oxida-
tive stress coupled with subsequent renal vasoconstric-
tion, was found to be a major discriminating factor
associated with the initiation phase of S-AKI. Further-
more, our data suggest that in pigs developing S-AKI,
renal circulation might not participate in sepsis-induced
systemic vasodilatation. However, the intensity of renal
vasoconstriction varies widely and appears to be model
specific.
Ideally, animal models of sepsis-induced AKI should
reproduce the mechanisms and consequences of human
sepsis, including the complex supportive treatment. To
increase the relevance of these models, they also should
exhibit a heterogeneous response to sepsis that is com-
parable to that in humans [11]. In our study, 50% of
animals developed S-AKI, a finding consistent with
recent multicenter epidemiologic studies showing that
in 40% to 50% of sepsis patients, concomitant AKI
develops [4-6]. In addition, an early (that is, within 22
hours) development of S-AKI observed in our models
also closely mimics a pattern seen typically in clinical
studies [17]. The separation of animals into those with
and without S-AKI according to the AKIN definition
was associated with a number of significant physiologi-
cal differences, adding validity and usefulness to this
approach.
The most salient feature of the present study is the
considerable variability in renal hemodynamic responses
to sepsis despite a homogeneous and reproducible pat-
tern of systemic hemodynamics and a uniform level of
supportive treatment. This finding is somewhat contra-
dictory to the results of a recent comprehensive review
of the available experimental evidence, demonstrating
that in the presence of preserved or increased cardiac
output, renal blood flow is typically maintained or
increased [18]. Similar predictive value was shown for
calculated renal vascular resistance, although extraordin-
ary heterogeneity exists [19]. We could consistently
observe the link between well-maintained cardiac output
and preserved renal blood flow only in those septic ani-
mals that remained AKI free. By contrast, in animals
that developed AKI, sepsis is often accompanied by an
uncoupling between systemic (reduced) and renal vascu-
lar resistance (increased), resulting in reduced renal
blood flow despite maintained or even increased cardiac
output. In contrast to all previous experiments, our
study is the first to determine renal vascular resistance
by using the directly measured renal venous pressure
and to compare the differences between dynamic
changes in renal vascular resistance in AKI-free and
AKI-positive subjects. In this context, our results sug-
gest that renal circulation might behave differently in
pigs with S-AKI as opposed to S-AKI-free animals and
that the renal circulatory response to sepsis cannot reli-
ably be predicted from changes in systemic hemody-
namics. Moreover, the divergent renal circulatory
response observed in a majority of S-AKI animals sup-
ports the existence of the phenomenon of selective renal
vasoconstriction, even in large-animal models with
apparent sepsis-induced systemic vasodilatation [20].
Our observation is congruent with the clinical data of
Lerolle et al.[ 2 1 ] ,w h or e c e n t l yd e m o n s t r a t e dt h a tt h e
increased Doppler resistive index, assessed at ICU
admission as a surrogate measure of intrarenal vascular
resistance, was significantly higher in septic shock
patients in whom S-AKI subsequently developed. Con-
versely, our results markedly differ from a series of stu-
dies done by the Australian research group in a sheep
sepsis model induced by continuous Escherichia coli
infusion, in which S-AKI was uniformly associated with
significant renal vasodilatation and increased renal artery
blood flow [22-25]. Although the reasons for this discre-
pancy are not readily apparent, differences between spe-
cies (sheep are ruminants) in regard to renal responses
to sepsis, different bacterial insults (E. coli versus Pseu-
domonas vs. polymicrobial peritonitis) and the use of
conscious versus anesthetized animals can be taken into
consideration [18,26].
Based on the data presented here, we cannot unam-
biguously determine the cause of elevated renal vascular
resistance. Recently, we observed gradually increased
renal venous pressure with an early reduction in renal
cortex microvascular perfusion during progressive por-
cine sepsis, each potentially contributing to the increase
in renal resistance [15]. Although both renal venous
congestion and deterioration in cortex microcirculation
developed in this study, none of these variables differed
from those in AKI-free animals. Renal interstitial tissue
edema, more pronounced microvascular blood-flow
derangement in deeper cortex layers and medulla not
detected by our approach, and altered renal vasculature
might have been factors implicated in the increased flow
resistance in the S-AKI group. Whatever the mechan-
isms accounting for the increased renal resistance, the
design of the present study does not allow one to
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striction and kidney injury nor to clarify its relative con-
tribution to S-AKI. However, reduced renal oxygen
consumption, combined with signs of metabolic stress,
as evidenced by increased renal venous base deficit
implies an impairment of normal aerobic respiration.
Because we did not calculate renal oxygen consumption
per sodium reabsorbed, we can only speculate to what
extent the oxygen consumption was affected by per-
turbed mitochondrial function or altered efficiency for
tubular sodium transport. Nevertheless, considering the
unchanged renal lactate clearance and oxygen extraction
ratio (data not shown), it is plausible to speculate that
the reduction in renal oxygen consumption represents
decreasing oxygen demand rather than exhaustion of
renal oxidative metabolism.
The onset of AKI was preceded by early and remark-
able inflammatory response and oxidative stress. Despite
comparable septic insult and indistinguishable systemic
hemodynamic response, only those pigs that developed
AKI had a very early increase in the plasma levels of
TNF-a and TBARS. A similar pattern, albeit not statisti-
cally significant, was observed in the time-dependent
changes of plasma IL-6 levels. These findings corrobo-
rate emerging evidence from laboratory and clinical stu-
dies suggesting that AKI in sepsis has a prominent
inflammatory component in both the initiation and the
extension phases of the kidney injury [12,27,28]. Several
large cohorts of critically ill patients demonstrated that
IL-6 could be a robust predictor of AKI [9]. In keeping
with our findings, Murugan et al. [10] recently demon-
strated different immune response to pulmonary infec-
tion in patients with AKI as opposed to patients without
AKI. Patients admitted with pneumonia and who pre-
sented with or developed concomitant S-AKI had higher
plasma levels of IL-6 and TNF-a than did non-AKI
patients. Although our studyi sn o tt h ef i r s tt oa s s e s s
the association between inflammation and the suscept-
ibility to S-AKI, it extends the clinical observations by
demonstrating the temporal relation between early,
exaggerated inflammatory and oxidative stress response
and AKI, thus supporting the cause-effect interplay
between AKI and abnormal immune response.
Another major feature of this study is the comparison
of renal responses in two different sepsis models. To
our knowledge, we are the first to demonstrate renal
physiology in two different large-animal models of sep-
sis. First, they displayed differences with respect to the
renal vascular response to sepsis. Although the ratio of
renal to systemic vascular resistance increased in both
groups when compared with baseline values, the
increase in renal vascular resistance was more remark-
able in pigs challenged with intravenous bacteria infu-
sion. However, as shown in Figures 3 and 4, the
individual responses were heterogeneous. The exact
mechanism(s) responsible for different renal vascular
responses cannot be inferred from our data. The preser-
vation of urine output in the Infusion group was likely
caused by an increase in the hydrostatic pressure of the
glomerular capillaries, indicating that infusion of live
bacteria elicited more vasoconstriction in the efferent
than in the afferent arteriole of the glomerulus, which is
in sharp contrast to results observed in a sheep model
by Langenberg et al. [23]. Different renal vascular
responses might be attributable to different immune
responses. Only in those pigs in the Peritonitis group
that developed S-AKI, was a significant, albeit transient,
increase present in the production of nitric oxide and
oxidative stress, as revealed by changes in plasma levels
of NOx and TBARS, respectively. These results could
explain the relatively preserved renal vascular resistance
in the Peritonitis-induced AKI model. In addition, the
inflammatory response evaluated by plasma IL-6 levels
appeared to be more pronounced in this model than
that elicited by bacteria infusion. Of note, S-AKI devel-
oped more frequently in the Peritonitis group (62%) as
compared with the Infusion group (40%). Collectively,
these data support a prominent role of abnormal host
response to the infection in the development of S-AKI
and suggest that renal vasoconstriction might not neces-
sarily be a prerequisite for AKI to develop, at least in
the Peritonitis model [7]. Although inconclusive data
exist regarding the association of AKI and primary
infectious source [5,17,29], our data admit the depen-
dence of physiological renal responses on the causative
agent(s) and infectious source. Certainly, knowing histo-
pathologic findings in all particular subgroups would
allow us to put the data into a more comprehensive pic-
ture. Because renal tissue samples taken from our ani-
mals are scheduled for detailed genomic and proteomic
analyses, we were unable to provide morphologic data at
this stage.
Conclusions
In conclusion, we aimed to assess variability in renal
physiology and to study both hemodynamic and nonhe-
modynamic factors discriminating AKI from non-AKI in
two different large-animal models that closely resemble
human sepsis. The lessons that can be drawn from these
models are that (a) they exhibited marked heterogeneity
in susceptibility to the development of septic AKI that is
comparable to that in humans; and (b) the differences
between those animals that developed AKI and those
that did not are noteworthy from both the clinical and
research perspectives. First, although sepsis appears to
be a uniform clinical entity, much variation can be seen
in the renal responses. This variability has to be taken
into account when effects of therapeutic interventions
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Page 12 of 14are to be assessed. Second, renal circulatory response to
s e p s i sc a n n o tr e l i a b l yb ep r e d i c t e ds i m p l yf r o mc h a n g e s
in systemic hemodynamics. Renal blood flow can exhibit
significant variability, even though cardiac output is
maintained or increased. Third, the development of S-
AKI is often accompanied by an uncoupling between
systemic and renal vascular resistance, suggesting that
renal circulation does not participate in sepsis-induced
systemic vasodilatation. Fourth, early abnormal host
response seems to be a major pathobiologic factor asso-
ciated with the development of S-AKI. Fifth, the inten-
sity of immune and renal hemodynamic responses
appears to be model specific. The different renal
responses of these models to sepsis could allow future
studies to tease apart the underlying pathophysiology of
S-AKI.
Key messages
￿ Although sepsis appears to be a uniform clinical
entity, much variation can occur in the renal hemo-
dynamic and functional responses. This variability
has to be taken into account when effects of thera-
peutic interventions are to be assessed.
￿ Early abnormal host immune response appears to
be the major pathobiologic factor predicting the
development of porcine septic AKI.
￿ Renal circulatory response to sepsis in animals
d e v e l o p i n gA K Ic a n n o tr e l i a b l yb ep r e d i c t e df r o m
changes in systemic hemodynamics.
￿ Development of septic AKI is often accompanied
by an uncoupling between systemic and renal vascu-
lar resistance, suggesting that renal circulation does
not participate in sepsis-induced systemic
vasodilatation.
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